Standout Papers

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised... 2016 2026 2019 2022 362
  1. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial (2016)
    Peter M. Villiger, Sabine Adler et al. The Lancet

Immediate Impact

1 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
2024 Standout
Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
3 intermediate papers

Works of Diana Dan being referenced

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
2016 Standout

Author Peers

Author Last Decade Papers Cites
Diana Dan 358 28 325 124 23 590
P. Cohen 182 33 246 96 19 535
Mathieu Vautier 219 45 264 74 32 591
JC Piette 390 27 166 73 21 604
Seerapani Gopaluni 231 29 476 228 28 660
Y. Schoindre 234 20 249 77 25 704
José Valverde 297 26 372 72 32 647
T. Ponge 365 21 465 88 49 679
Richard Wernick 294 6 136 59 21 550
Jesús Rodríguez 431 9 180 60 39 739
Cornelis A. Verburgh 166 19 373 139 21 604

All Works

Loading papers...

Rankless by CCL
2026